Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Starling Oncology Inc., 3 years.
Starling Oncology Inc.
Director
AdaptHealth Corp.
Director · Interim CEO
Chief executive roles
Until May 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2025 | Starling Oncology Inc. | Other | −287,756 | — | — |
| Jun 18, 2025 | Starling Oncology Inc. | Derivative conversion | +620,400 | — | — |
| Jun 17, 2025 | Starling Oncology Inc. | In-the-money exercise | +679,224 | $1.20 | $815,069 |
| Jun 17, 2025 | Starling Oncology Inc. | Derivative conversion | +159,500 | — | — |
| Jun 17, 2025 | Starling Oncology Inc. | Shares withheld for tax | −311,128 | $2.62 | $815,155 |
| Mar 26, 2025 | Starling Oncology Inc. | Open-market purchase | +1,358,448 | $1.04 | $1,412,786 |
| Nov 22, 2024 | Starling Oncology Inc. | Grant or award | +80,000 | — | — |
| Jun 18, 2024 | AdaptHealth Corp. | Shares withheld for tax | −3,559 | $9.89 | $35,199 |
| May 7, 2024 | AdaptHealth Corp. | Shares withheld for tax | −8,547 | $9.85 | $84,188 |
| Apr 30, 2024 | AdaptHealth Corp. | Grant or award | +8,829 | — | — |
| Mar 2, 2024 | AdaptHealth Corp. | Grant or award | +21,206 | — | — |
| Feb 29, 2024 | AdaptHealth Corp. | Shares withheld for tax | −8,984 | $10.23 | $91,906 |
| Jan 2, 2024 | AdaptHealth Corp. | Shares withheld for tax | −9,226 | $7.26 | $66,981 |
| Dec 29, 2023 | AdaptHealth Corp. | Grant or award | +22,291 | — | — |
| Dec 26, 2023 | Starling Oncology Inc. | Grant or award | +80,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.